These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33791036)

  • 1. Scientific and technical guidance on foods for special medical purposes in the context of Article 3 of Regulation (EU) No 609/2013.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06544. PubMed ID: 33791036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance on the preparation and presentation of applications for exemption from mandatory labelling of food allergens and/or products thereof pursuant to Article 21 (2) of Regulation (EU) No 1169/2011.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06543. PubMed ID: 33791035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific and technical guidance for the preparation and presentation of a dossier for evaluation of an infant and/or follow-on formula manufactured from protein hydrolysates (Revision 1).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Loveren HV; Vinceti M; Willatts P; Fewtrell M; Przyrembel H; Titz A; Martínez SV
    EFSA J; 2021 Mar; 19(3):e06556. PubMed ID: 33791040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidance on the preparation and submission of the notification and application for authorisation of traditional foods from third countries in the context of Regulation (EU) 2015/2283 (Revision 1).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Schlatter J; Gelbmann W; de Sesmaisons-Lecarré A; Verhagen H; van Loveren H
    EFSA J; 2021 Mar; 19(3):e06557. PubMed ID: 33791041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 3).
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06554. PubMed ID: 33791038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidance on the preparation and submission of an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283 (Revision 1)
    ; Nutrition ; Nda A; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Salminen S; Schlatter J; Arcella D; Gelbmann W; de Sesmaisons-Lecarré A; Verhagen H; van Loveren H
    EFSA J; 2021 Mar; 19(3):e06555. PubMed ID: 33791039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General scientific guidance for stakeholders on health claim applications (Revision 1).
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06553. PubMed ID: 33791037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow-on formula manufactured from protein hydrolysates.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Fewtrell M; Przyrembel H; Titz A; Valtueña Martínez S
    EFSA J; 2017 May; 15(5):e04779. PubMed ID: 32625485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 2).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Heng L; Valtueña Martínez S; Siani A
    EFSA J; 2017 Jan; 15(1):e04680. PubMed ID: 32625270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of the extension of use of galacto-oligosaccharides (GOS) as a novel food in food for special medical purposes pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Prieto Maradona M; Schlatter JR; van Loveren H; Colombo P; Knutsen HK
    EFSA J; 2022 Mar; 20(3):e07203. PubMed ID: 35386574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientific substantiation of health claims in the EU.
    Flynn A
    Proc Nutr Soc; 2012 Feb; 71(1):120-6. PubMed ID: 21933455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance on safety evaluation of sources of nutrients and bioavailability of nutrient from the sources (Revision 1).
    ; Younes M; Aggett P; Aguilar F; Crebelli R; Dusemund B; Filipič M; Frutos MJ; Galtier P; Gundert-Remy U; Kuhnle GG; Lambré C; Leblanc JC; Lillegaard IT; Moldeus P; Mortensen A; Oskarsson A; Stankovic I; Waalkens-Berendsen I; Woutersen RA; Wright M; Di Domenico A; Fairweather-Tait S; McArdle HJ; Smeraldi C; Gott D
    EFSA J; 2021 Mar; 19(3):e06552. PubMed ID: 33815621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extension of use of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Prieto Maradona M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; van Loveren H; Albert O; de Sesmaisons Lecarré A; Knutsen HK
    EFSA J; 2021 Nov; 19(11):e06843. PubMed ID: 34804232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scientific Guidance for the submission of dossiers on Food Enzymes.
    ; Lambré C; Barat Baviera JM; Bolognesi C; Cocconcelli PS; Crebelli R; Gott DM; Grob K; Lampi E; Mengelers M; Mortensen A; Rivière G; Steffensen IL; Tlustos C; Van Loveren H; Vernis L; Zorn H; Glandorf B; Herman L; Aguilera J; Andryszkiewicz M; Gomes A; Kovalkovicova N; Liu Y; Rainieri S; Chesson A
    EFSA J; 2021 Oct; 19(10):e06851. PubMed ID: 34721697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of an extension of use of
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Aguilera-Gómez M; Cubadda F; Frenzel T; Heinonen M; Prieto Maradona M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; Siskos A; van Loveren H; Ackerl R; Knutsen HK
    EFSA J; 2023 Nov; 21(11):e8416. PubMed ID: 38035143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scientific Opinion related to a notification from Lyckeby Starch AB on barley starch to be used in the manufacturing of several foods as ingredient, of the food additive modified starch and of glucose syrups pursuant to Article 21(2) of Regulation (EU) No 1169/2011 - for permanent exemption from labelling.
    ; Turck D; Castenmiller J; Hirsch Ernst KI; Kearney J; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Marchelli R; van Loveren H; Martínez SV; de Henauw S
    EFSA J; 2020 May; 18(5):e06118. PubMed ID: 37649494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientific Guidance on the data required for the risk assessment of flavourings to be used in or on foods.
    ; Younes M; Aquilina G; Castle L; Degen G; Fowler PJ; Fernandez MJF; Fürst P; Gundert-Remy U; Gürtler R; Husøy T; Manco M; Mennes W; Moldeus P; Passamonti S; Shah R; Waalkens-Berendsen I; Wölfle D; Wright M; Benigni R; Bolognesi C; Boon P; Chipman K; De Knecht J; Nørby K; Arcella D; Barmaz S; Carfì M; Laganaro M; Martino C; Tard A; Vianello G; Engel KH
    EFSA J; 2022 Dec; 20(12):e07673. PubMed ID: 36579172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel foods in the European Union: Scientific requirements and challenges of the risk assessment process by the European Food Safety Authority.
    Ververis E; Ackerl R; Azzollini D; Colombo PA; de Sesmaisons A; Dumas C; Fernandez-Dumont A; Ferreira da Costa L; Germini A; Goumperis T; Kouloura E; Matijevic L; Precup G; Roldan-Torres R; Rossi A; Svejstil R; Turla E; Gelbmann W
    Food Res Int; 2020 Nov; 137():109515. PubMed ID: 33233150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientific opinion on the evaluation of authorised ferric sodium EDTA as an ingredient in the context of Regulation (EC) 258/97 on novel foods and Regulation (EU) 609/2013 on food intended for infants and young children, food for special medical purposes and total diet replacement for weight control.
    ; Younes M; Aggett P; Aguilar F; Crebelli R; Dusemund B; Filipič M; Frutos MJ; Galtier P; Gundert-Remy U; Kuhnle GG; Lambré C; Leblanc JC; Lillegaard IT; Moldeus P; Mortensen A; Oskarsson A; Stankovic I; Waalkens-Berendsen I; Woutersen RA; Wright M; Tobback P; Mcardle H; Germini A; Gott D
    EFSA J; 2018 Aug; 16(8):e05369. PubMed ID: 32626017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of vitamin D
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Prieto Maradona M; Schlatter JR; van Loveren H; Gerazova-Efremova K; Roldán-Torres R; Knutsen HK
    EFSA J; 2022 Jun; 20(6):e07326. PubMed ID: 35706680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.